This inventor holds 2 USPTO granted patents. Top assignees: Artecel Science, Inc., Artecel Sciences Inc.. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2003
Title: The Innovative Journey of Naima Moustaid-Moussa
Introduction
Naima Moustaid-Moussa, an accomplished inventor based in Knoxville, TN, has made significant strides in the field of medical research, particularly concerning obesity and diabetes. With a total of two patents to her name, her innovative work focuses on the modulation of key receptors and calcium levels in adipocytes, showcasing her dedication to addressing pressing health issues.
Latest Patents
Moustaid-Moussa's latest invention revolves around the "Modulation of the sulfonylurea receptor and calcium in adipocytes for treatment of obesity/diabetes." This cutting-edge invention presents methods for determining the ability of compounds to regulate lipogenesis and lipolysis. By acting as a sulfonylurea-1 (SUR 1) potassium channel activator and an adipocyte potassium channel activator, her invention aims to enhance treatment options for obesity and diabetes. The recognition of the sulfonylurea receptor's presence in adipocytes highlights the potential impact of this research on future therapeutic approaches.
Career Highlights
Throughout her career, Naima Moustaid-Moussa has applied her expertise in various research settings. She has been associated with Artecel Science, Inc., where her work has contributed to advancements in understanding metabolic processes. Her contributions in these professional environments underline her commitment to research and innovation in the healthcare field.
Collaborations
Moustaid-Moussa has collaborated with notable scientists during her career, including William O. Wilkison and Michael B. Zemel. These collaborations have undoubtedly enriched her research and allowed for greater innovation through shared experiences and knowledge.
Conclusion
Naima Moustaid-Moussa stands out as a pioneer in the field of obesity and diabetes research. Her patents reflect her innovative spirit and her commitment to finding effective solutions for critical health challenges. As she continues her work, her contributions promise to influence the future of medical research and treatment methodologies significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile